DHCNI Miscellaneous

Diversified Healthcare Trust -

$17.72+4.24%

Price as of close on Nov 3, 2026 · Financials updated Oct 1, 2026

Basics

Sector: Miscellaneous
Industry: Miscellaneous
Enterprise value: 6.5B USD

Overall health

Not enough data: too little is reported yet for an overall view

Only 2 of 4 categories have enough reported data; an overall score needs at least 3.

Yahoo Finance doesn’t classify this company, so it is compared with other unclassified companies. That group mixes unrelated businesses, so its rankings are less meaningful than sector rankings.

See how it ranks against its peers

Worth knowing

Paying shareholders without free cash flow. Paid out $31M over the 3 fiscal years to 2025 with -$480M of free cash flow.
Diversified Healthcare Trust - returned $31M in buybacks and dividends over three fiscal years while its free cash flow totalled -$480M. The money came from its cash pile or from borrowing.
Not profitable yet. Reported a loss in the 12 months to June 2026.
Diversified Healthcare Trust - reported a net loss over the last twelve months, so earnings-based measures can't show it as cheap.

StockQuotient Score

—

Valuation

Is the price right?

14/100

Weak

2/3 inputs reported · Partial data

Since last quarter: No major changeValuation also moves with the share price every day.

Why

Weaker than most peers on:

▼ Earnings yield
▼ FCF yield

Compare with peers

Behind the score

Sector-normalized EBITDA, earnings, and free cash flow yields.

Earnings yield-6.2%

SEC filings · 12 months to Jun 2026Negative (a loss or cash outflow), so it counts as zero whatever the share price30% base weight · Z-score -1.13Sector median: 0.0930 · MAD: 0.0820

EBITDA yieldUnavailable

Missing · left out of the score · no sector data, so not countedNot counted · remaining weights rescaledSector median: 0.0595 · MAD: 0.0403

Free cash flow yield-3.6%

SEC filings · 12 months to Jun 2026 · operating cash flow − capital spendingNegative (a loss or cash outflow), so it counts as zero whatever the share price20% base weight · Z-score -1.00Sector median: 0.0162 · MAD: 0.0162

Other data (not scored)

Book yield36.9%

SEC filings · latest balance sheetReported valueInformational · 0% composite weightSector median: 0.6716 · MAD: 0.4443

Growth

Is it growing?

46/100

Moderate▼ 2 since Oct 27 close

3/3 inputs reported · High confidence

Since last quarter: No major change

Why it changed since the Oct 27, 2026 close: Score 48 → 46

Peer companies moved-2

Each step re-scores the company against its peers as they were on Oct 28, 2026; the parts add up to the change. Price effects on EBITDA yield are approximate.

Why

Held back by:

▼ Revenue growth

Compare with peers

Behind the score

Revenue and earnings-per-share growth over one year, and revenue growth over three years.

Earnings per share growthUnavailable

Still loss-making, but the loss per share narrowed33% base weight · Z-score 0.20Sector median: 0.1263 · MAD: 0.4644

3-year revenue growth3.5%

SEC filings · 3 years to Jun 2026Reported value33% base weight · Z-score 0.02Sector median: 0.0337 · MAD: 0.0767

Revenue growth-1.5%

SEC filings · 12 months to Jun 2026Reported value33% base weight · Z-score -0.51Sector median: 0.0583 · MAD: 0.1425

Profitability

Does it earn well?

Insufficient data

Insufficient data: 1 of 3 inputs reported (at least 2 needed). We leave it blank rather than fill the gap with a made-up middle value.

Risk

Debt, liquidity, price swings

Insufficient data

Insufficient data: 1 of 3 inputs reported (at least 2 needed). We leave it blank rather than fill the gap with a made-up middle value.

Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.

Questions investors ask about Diversified Healthcare Trust -

Is Diversified Healthcare Trust - getting weaker?: Its latest SEC filing (Aug 3, 2026) got stronger: net margin rose 3.4 points to -17.7%.
How is Diversified Healthcare Trust - valued vs its peers?: Priced higher than most peers relative to what it earns. Valuation scores 14/100 against 170 miscellaneous peers. Earnings yield -6.2% vs a peer median of 9.3% (weaker than 100% of peers).Earnings yield -6.2% vs peers 9.3% (weaker than 100% of peers).
Is Diversified Healthcare Trust - growing?: At about the same pace as its peers. Growth scores 46/100 against 170 miscellaneous peers. Revenue growth -1.5% vs a peer median of 5.8% (weaker than 66% of peers).Revenue growth -1.5% vs peers 5.8% (weaker than 66% of peers).
How profitable is Diversified Healthcare Trust -?: Insufficient data: 1 of 3 inputs reported (at least 2 needed).
How risky is Diversified Healthcare Trust -?: Insufficient data: 1 of 3 inputs reported (at least 2 needed).

Latest filing: what changed

Quarter ended Jun 30, 2026 · filed Aug 3, 2026 · compared with the quarter ended Mar 31, 2026

Got stronger

Net margin rose 3.4 points to -17.7%

	Previous quarter	Latest quarter	Change
Revenue (12 months)	1.5B USD	1.5B USD	−1.1%
Net income (12 months)	−320.2M USD	−266.0M USD	−16.9%
Free cash flow (12 months)	−150.4M USD	−155.0M USD	+3.1%
Debt	2.4B USD	2.4B USD	−0.0%
Cash	121.8M USD	116.8M USD	−4.1%
Shares outstanding	242.1M	242.1M	+0.0%

From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.

Financials

Fiscal years from SEC annual filings · change vs the prior year

Key ratios	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	Change
Net margin	12.6%	-1.2%	-20.8%	-24.8%	-18.6%	▲ 6.2 pts
Return on assets (ROA)	2.6%	-0.3%	-5.4%	-7.2%	-6.6%	▲ 0.7 pts
Return on equity (ROE)	6.6%	-0.6%	-12.6%	-18.9%	-17.2%	▲ 1.7 pts
Free cash flow margin	-21.0%	-26.5%	-15.9%	-6.0%	-10.8%	▼ 4.8 pts
Debt to equity	—	—	—	1.56×	1.47×	▼ 5.8%

DHCNI price history

Price history is added with the daily price update and will appear after the next one.

Similar companies

Sector leaderboards

Fabasoft AG0IWU.L79/ 100

Henderson Far East Income LimitedHFL.NZ78/ 100

Naturhouse Health, S.A.0R9G.L76/ 100

Bringing the fundamentals into focus…

Overall health

Not enough data: too little is reported yet for an overall view

Only 2 of 4 categories have enough reported data; an overall score needs at least 3.

Yahoo Finance doesn’t classify this company, so it is compared with other unclassified companies. That group mixes unrelated businesses, so its rankings are less meaningful than sector rankings.

See how it ranks against its peers

Worth knowing

Paying shareholders without free cash flow. Paid out $31M over the 3 fiscal years to 2025 with -$480M of free cash flow.

Diversified Healthcare Trust - returned $31M in buybacks and dividends over three fiscal years while its free cash flow totalled -$480M. The money came from its cash pile or from borrowing.

Not profitable yet. Reported a loss in the 12 months to June 2026.

Diversified Healthcare Trust - reported a net loss over the last twelve months, so earnings-based measures can't show it as cheap.

Questions investors ask about Diversified Healthcare Trust -

Is Diversified Healthcare Trust - getting weaker?

Its latest SEC filing (Aug 3, 2026) got stronger: net margin rose 3.4 points to -17.7%.

How is Diversified Healthcare Trust - valued vs its peers?

Priced higher than most peers relative to what it earns. Valuation scores 14/100 against 170 miscellaneous peers. Earnings yield -6.2% vs a peer median of 9.3% (weaker than 100% of peers).Earnings yield -6.2% vs peers 9.3% (weaker than 100% of peers).

Is Diversified Healthcare Trust - growing?

At about the same pace as its peers. Growth scores 46/100 against 170 miscellaneous peers. Revenue growth -1.5% vs a peer median of 5.8% (weaker than 66% of peers).Revenue growth -1.5% vs peers 5.8% (weaker than 66% of peers).

How profitable is Diversified Healthcare Trust -?

Insufficient data: 1 of 3 inputs reported (at least 2 needed).

How risky is Diversified Healthcare Trust -?

Insufficient data: 1 of 3 inputs reported (at least 2 needed).

Previous quarter

Latest quarter

Change

Revenue (12 months)

1.5B USD

1.5B USD

−1.1%

Net income (12 months)

−320.2M USD

−266.0M USD

−16.9%

Free cash flow (12 months)

−150.4M USD

−155.0M USD

+3.1%

Debt

2.4B USD

2.4B USD

−0.0%

Cash

121.8M USD

116.8M USD

−4.1%

Shares outstanding

242.1M

242.1M

+0.0%

Key ratios

FY 2021

FY 2022

FY 2023

FY 2024

FY 2025

Change

Net margin

12.6%

-1.2%

-20.8%

-24.8%

-18.6%

▲ 6.2 pts

Return on assets (ROA)

2.6%

-0.3%

-5.4%

-7.2%

-6.6%

▲ 0.7 pts

Return on equity (ROE)

6.6%

-0.6%

-12.6%

-18.9%

-17.2%

▲ 1.7 pts

Free cash flow margin

-21.0%

-26.5%

-15.9%

-6.0%

-10.8%

▼ 4.8 pts

Debt to equity

—

1.56×

1.47×

▼ 5.8%